Sergey Mashko

Sergey Mashko


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2009 in BMC Molecular Biology
Verified
Journal Article
Open access
PDF file
JKJoanna I Katashkina
Joanna I Katashkina
YHYoshihiko Hara
Yoshihiko Hara
LGLyubov I Golubeva
Lyubov I Golubeva
IAIrina G Andreeva
Irina G Andreeva
TKTatiana M Kuvaeva
Tatiana M Kuvaeva
SMSergey Mashko
Sergey Mashko
Background: Pantoea ananatis, a member of the Enterobacteriacea family, is a new and promising subject for biotechnological research. Over recent years, impressive progress in its application to L-glutamate production has been achieved. Nevertheless, genetic and biotechnological studies of Pantoea ananatis have been impeded because of the absence of genetic tools for rapid construction of direct mutations in this bacterium. The λ Red-recombineering technique previously developed in E. coli and used for gene inactivation in several other bacteria is a high-performance tool for rapid construction of precise genome modifications. Results: In this study, the expression of λ Red genes in P. ananatis was found to be highly toxic. A screening was performed to select mutants of P. ananatis that were resistant to the toxic affects of λ Red. A mutant strain, SC17(0) was identified that grew well under conditions of simultaneous expression of λ gam, bet, and exo genes. Using this strain, procedures for fast introduction of multiple rearrangements to the Pantoea ananatis genome based on the λ Red-dependent integration of the PCR-generated DNA fragments with as short as 40 bp flanking homologies have been demonstrated. Conclusion: The λ Red-recombineering technology was successfully used for rapid generation of chromosomal modifications in the specially selected P. ananatis recipient strain. The procedure of electro-transformation with chromosomal DNA has been developed for transfer of the marked mutation between different P. ananatis strains. Combination of these techniques with λ Int/Xis-dependent excision of selective markers significantly accelerates basic research and construction of producing strains.

1 January 2008 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
NMNatalia I Minaeva
Natalia I Minaeva
EGEvgeny R Gak
Evgeny R Gak
Danila ZimenkovDanila Zimenkov
Danila Zimenkov
ASAleksandra Y Skorokhodova
Aleksandra Y Skorokhodova
IBIrina V Biryukova
Irina V Biryukova
SMSergey Mashko
Sergey Mashko
The development of modern producer strains with metabolically engineered pathways poses special problems that often require manipulating many genes and expressing them individually at different levels or under separate regulatory controls. The construction of plasmid-less marker-less strains has many advantages for the further practical exploitation of these bacteria in industry. Such producer strains are usually constructed by sequential chromosome modifications including deletions and integration of genetic material. For these purposes complex methods based on in vitro and in vivo recombination processes have been developed.

23 June 2009 in Molecular Biology
Verified
Journal Article
Closed access
PDF file
AGA. Yu. Gulevich
A. Yu. Gulevich
ASA. Yu. Skorokhodova
A. Yu. Skorokhodova
VEVladimir Yu Ermishev
Vladimir Yu Ermishev
AKA. A. Krylov
A. A. Krylov
NMN. I. Minaeva
N. I. Minaeva
SMSergey Mashko
Sergey Mashko
A new method for the construction of translationally coupled operons in a bacterial chromosome was developed on the basis of the recombineering approach. The method includes the in vitro construction...

19 November 2014 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
MSMikhail S Shupletsov
Mikhail S Shupletsov
LGLyubov I Golubeva
Lyubov I Golubeva
SRSvetlana S Rubina
Svetlana S Rubina
DPDmitry A Podvyaznikov
Dmitry A Podvyaznikov
SIShintaro Iwatani
Shintaro Iwatani
SMSergey Mashko
Sergey Mashko
Steady-state 13C-based metabolic flux analysis (13C-MFA) is the most powerful method available for the quantification of intracellular fluxes. These analyses include concertedly linked experimental and computational stages: (i) assuming the metabolic model and optimizing the experimental design; (ii) feeding the investigated organism using a chosen 13C-labeled substrate (tracer); (iii) measuring the extracellular effluxes and detecting the 13C-patterns of intracellular metabolites; and (iv) computing flux parameters that minimize the differences between observed and simulated measurements, followed by evaluating flux statistics. In its early stages, 13C-MFA was performed on the basis of data obtained in a single labeling experiment (SLE) followed by exploiting the developed high-performance computational software. Recently, the advantages of parallel labeling experiments (PLEs), where several LEs are conducted under the conditions differing only by the tracer(s) choice, were demonstrated, particularly with regard to improving flux precision due to the synergy of complementary information. The availability of an open-source software adjusted for PLE-based 13C-MFA is an important factor for PLE implementation. The open-source software OpenFLUX, initially developed for the analysis of SLEs, was extended for the computation of PLE data. Using the OpenFLUX2, in silico simulation confirmed that flux precision is improved when 13C-MFA is implemented by fitting PLE data to the common model compared with SLE-based analysis. Efficient flux resolution could be achieved in the PLE-mediated analysis when the choice of tracer was based on an experimental design computed to minimize the flux variances from different parts of the metabolic network. The analysis provided by OpenFLUX2 mainly includes (i) the optimization of the experimental design, (ii) the computation of the flux parameters from LEs data, (iii) goodness-of-fit testing of the model’s adequacy, (iv) drawing conclusions concerning the identifiability of fluxes and construction of a contribution matrix reflecting the relative contribution of the measurement variances to the flux variances, and (v) precise determination of flux confidence intervals using a fine-tunable and convergence-controlled Monte Carlo-based method. The developed open-source OpenFLUX2 provides a friendly software environment that facilitates beginners and existing OpenFLUX users to implement LEs for steady-state 13C-MFA including experimental design, quantitative evaluation of flux parameters and statistics.

23 June 2011 in Applied Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
VAValerii Z. Akhverdyan
Valerii Z. Akhverdyan
EGEvgueni R. Gak
Evgueni R. Gak
ITIrina L. Tokmakova
Irina L. Tokmakova
NSNataliya V. Stoynova
Nataliya V. Stoynova
YYYurgis A. V. Yomantas
Yurgis A. V. Yomantas
SMSergey Mashko
Sergey Mashko
The advantages of phage Mu transposition-based systems for the chromosomal editing of plasmid-less strains are reviewed. The cis and trans requirements for Mu phage-mediated transposition, which include the L/R ends of the Mu DNA, the transposition factors MuA and MuB, and the cis/trans functioning of the E element as an enhancer, are presented. Mini-Mu(LR)/(LER) units are Mu derivatives that lack most of the Mu genes but contain the L/R ends or a properly arranged E element in cis to the L/R ends. The dual-component system, which consists of an integrative plasmid with a mini-Mu and an easily eliminated helper plasmid encoding inducible transposition factors, is described in detail as a tool for the integration/amplification of recombinant DNAs. This chromosomal editing method is based on replicative transposition through the formation of a cointegrate that can be resolved in a recombination-dependent manner. (E-plus)- or (E-minus)-helpers that differ in the presence of the trans-acting E element are used to achieve the proper mini-Mu transposition intensity. The systems that have been developed for the construction of stably maintained mini-Mu multi-integrant strains of Escherichia coli and Methylophilus methylotrophus are described. A novel integration/amplification/fixation strategy is proposed for consecutive independent replicative transpositions of different mini-Mu(LER) units with “excisable” E elements in methylotrophic cells.

15 March 2018 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
EMEvgeniya A. Malykh
Evgeniya A. Malykh
IBIvan A. Butov
Ivan A. Butov
ARAnna B. Ravcheeva
Anna B. Ravcheeva
AKAlexander A. Krylov
Alexander A. Krylov
SMSergey Mashko
Sergey Mashko
NSNataliya Stoynova
Nataliya Stoynova
In the l-histidine (His) biosynthetic pathway of Escherichia coli, the first key enzyme, ATP-phosphoribosyltransferase (ATP-PRT, HisG), is subject to different types of inhibition. Eliminating the feedback inhibition of HisG by the His end product is an important step that enables the oversynthesis of His in breeding strains. However, the previously reported feedback inhibition-resistant mutant enzyme from E. coli, HisGE271K, is inhibited by purine nucleotides, particularly ADP and AMP, via competitive inhibition with its ATP substrate. 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR), which is formed not only during His biosynthesis but also during de novo purine biosynthesis, acts as a natural analog of AMP and substitutes for it in some enzymatic reactions. We hypothesized that AICAR could control its own formation, particularly through the His biosynthetic pathway, by negatively influencing HisG enzymatic activity, which would make preventing ATP-PRT transferase inhibition by AICAR crucial for His overproduction. For the first time, both the native E. coli HisG and the previously described feedback-resistant mutant HisGE271K enzymes were shown to be sensitive to inhibition by AICAR, a structural analog of AMP. To circumvent the negative effect that AICAR has on His synthesis, we constructed the new His-producing strain EA83 and demonstrated its improved histidine production. This increased production was particularly associated with the improved conversion of AICAR to ATP due to purH and purA gene overexpression; additionally, the PitA-dependent phosphate/metal (Me2+-Pi) transport system was modified by a pitA gene deletion. This His-producing strain unexpectedly exhibited decreased alkaline phosphatase activity at low Pi concentrations. AICAR was consequently hypothesized inhibit the two-component PhoBR system, which controls Pho regulon gene expression. Inhibition of a key enzyme in the His biosynthetic pathway, HisG, by AICAR, which is formed in this pathway, generates a serious bottleneck during His production. The constructed His-producing strain demonstrated the enhanced expression of genes that encode enzymes involved in the metabolism of AICAR to ATP, which is a substrate of HisG, and thus led to improved His accumulation.